Canada · Delayed Price · Currency is CAD Novo Nordisk Statistics
Total Valuation
Novo Nordisk has a market cap or net worth of CAD 299.20 billion. The enterprise value is 321.69 billion.
| Market Cap | 299.20B |
| Enterprise Value | 321.69B |
Important Dates
The last earnings date was Wednesday, February 4, 2026.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | Aug 18, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.34% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 3.19B |
Valuation Ratios
The trailing PE ratio is 13.55 and the forward PE ratio is 14.88.
| PE Ratio | 13.55 |
| Forward PE | 14.88 |
| PS Ratio | 4.49 |
| PB Ratio | 7.15 |
| P/TBV Ratio | 21.69 |
| P/FCF Ratio | 23.54 |
| P/OCF Ratio | 11.65 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.60, with an EV/FCF ratio of 25.31.
| EV / Earnings | 14.57 |
| EV / Sales | 4.81 |
| EV / EBITDA | 9.60 |
| EV / EBIT | 10.58 |
| EV / FCF | 25.31 |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 0.67.
| Current Ratio | 0.80 |
| Quick Ratio | 0.54 |
| Debt / Equity | 0.67 |
| Debt / EBITDA | 0.85 |
| Debt / FCF | 2.22 |
| Interest Coverage | 33.42 |
Financial Efficiency
Return on equity (ROE) is 60.70% and return on invested capital (ROIC) is 41.13%.
| Return on Equity (ROE) | 60.70% |
| Return on Assets (ROA) | 17.43% |
| Return on Invested Capital (ROIC) | 41.13% |
| Return on Capital Employed (ROCE) | 42.97% |
| Weighted Average Cost of Capital (WACC) | 6.13% |
| Revenue Per Employee | 963,417 |
| Profits Per Employee | 319,308 |
| Employee Count | 69,150 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 1.20 |
Taxes
In the past 12 months, Novo Nordisk has paid 6.06 billion in taxes.
| Income Tax | 6.06B |
| Effective Tax Rate | 21.53% |
Stock Price Statistics
| Beta (5Y) | 0.40 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 5.53 |
| 200-Day Moving Average | 6.15 |
| Relative Strength Index (RSI) | 41.13 |
| Average Volume (20 Days) | 145,129 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novo Nordisk had revenue of CAD 66.62 billion and earned 22.08 billion in profits. Earnings per share was 4.96.
| Revenue | 66.62B |
| Gross Profit | 54.90B |
| Operating Income | 30.31B |
| Pretax Income | 28.14B |
| Net Income | 22.08B |
| EBITDA | 33.04B |
| EBIT | 30.31B |
| Earnings Per Share (EPS) | 4.96 |
Balance Sheet
The company has 5.81 billion in cash and 28.23 billion in debt, with a net cash position of -22.42 billion.
| Cash & Cash Equivalents | 5.81B |
| Total Debt | 28.23B |
| Net Cash | -22.42B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 41.83B |
| Book Value Per Share | 9.41 |
| Working Capital | -9.31B |
Cash Flow
In the last 12 months, operating cash flow was 25.67 billion and capital expenditures -12.96 billion, giving a free cash flow of 12.71 billion.
| Operating Cash Flow | 25.67B |
| Capital Expenditures | -12.96B |
| Free Cash Flow | 12.71B |
| FCF Per Share | n/a |
Margins
Gross margin is 82.41%, with operating and profit margins of 45.50% and 33.14%.
| Gross Margin | 82.41% |
| Operating Margin | 45.50% |
| Pretax Margin | 42.24% |
| Profit Margin | 33.14% |
| EBITDA Margin | 49.60% |
| EBIT Margin | 45.50% |
| FCF Margin | 19.08% |
Dividends & Yields
This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 3.05%.
| Dividend Per Share | 0.15 |
| Dividend Yield | 3.05% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 50.53% |
| Buyback Yield | 0.34% |
| Shareholder Yield | 3.39% |
| Earnings Yield | 7.38% |
| FCF Yield | 4.25% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Novo Nordisk has an Altman Z-Score of 5.15 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.15 |
| Piotroski F-Score | 5 |